Julin Opanuraks

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Treatment options for castration-resistant prostate cancer (CRPC) are available, but clear instructions for the selection of appropriate treatment are lacking. A meeting of urology experts based in Thailand was convened with the following objectives: (1) to reach a consensus and share real-life experiences about how to identify CRPC; (2) to choose the(More)
  • 1